Does use of livers with microvesicular fat safely expand the donor pool?
Livers with even severe microvesicular steatosis can be reliably used for transplantation without the fear of high rates of primary nonfunction. There was a significant incidence of poor early graft function, but this did not affect outcome. Microsteatosis is usually associated with some underlying risk factor in the donor and is reversible, as demonstrated by follow-up biopsies after transplant.
Voice therapy is effective in improving voice quality as assessed by self rated and observer rated methods.